WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 10'9701 Infant (under 12 months) mortality rate: 152
GDP / capita (US$): 15'0921 Child (under 5 years) mortality rate: 212

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 21  21  21  20  20  19  15  12 
Births
Surviving infants
Pop. less than 5 years
Pop. less than 15 years
Female 15-49 years

Number of reported case

(Click for retrospective incidence data for Palau)
Diphtheria
Japanese encephalitis
Measles
Mumps
Pertussis
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Palau)
Vaccine year result method % card seen                                                
BCG         
DTP1          100  100  100  99  100  95 
DTP3          99  89  84  69  49  96 
HepB_BD          100  100  100  100  100  100 
HepB3          99  89  91  80  69  96 
Hib3          99  89  85  66  48  96 
JapEnc         
MCV          99  91  85  39  75  83 
MCV2          98  86  83  75 
PCV1          100  86  95  87  81 
PCV3          93  82  61  45  18 
Pol3          99  89  98  68  48  96 
Rota1          100  100  98  89  34 
Rota_last          99  89  89  76  15 
Rubella1          99  91  85  75 
TT2plus          26  100 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Palau)
DTP1 99  99  99  99  99  98  99 
DTP3 99  89  84  69  49  96  99 
HepB3 99  89  91  80  69  96 
HepB_BD 99  99  99  99  99  99 
Hib3 99  89  85  66  48  96 
MCV 99  91  85  39  75  83  98 
MCV2 86  86  83  39  79  75 
PCV3 93  82  61  45  18 
Pol3 99  89  98  68  48  96  99 
Rota_last 99  89  89  76  15 

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
DTaP 15 months; 4-5 years; Yes
DTaPHepIPV 6 week; 4, 6 months; Yes
HepB birth; 6 weeks; 6 months; Yes
Hib 6 weeks; 4, 6, 12 months; Yes
HPV 9-26 years; +2, +6 months; Yes
Influenza Elderly and risk groups
IPV 4-5 years; Yes
MenC_conj 11-18 years; Yes
MMR 12, 15 months; Yes
Pneumo_conj 3, 5, 7, 15 months; Yes
Rotavirus 6 week; 4, 6 months; Yes
Td 5-10 years;
Tdap 7-49 years; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  No  Yes  Yes  No  Yes  No 
What years does the MYP cover? number     2'012  2010-2011    2008-2012  NA 
Nº of districts with microplans that include activities to raise immunization coverage number      

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No         

System performance

Total Nº districts in country number        
Nº districts with DTP3 coverage >=80% number  
% of districts with DTP3 coverage >=80% From 0 to 100%         100 
Nº districts with measles (MCV1) coverage >=95% number        
% of districts with MCV1 coverage >=95% From 0 to 100%           100   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes    Yes  No 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100%    

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.